Author:
Boye Kristina S.,Tokar Erdemir Elif,Zimmerman Nathan,Reddy Abraham,Benneyworth Brian D.,Dabora Matan C.,Hankosky Emily R.,Bethel M. Angelyn,Clark Callahan,Lensing Cody J.,Sailer Scott,San Juan Ramira,Heine Robert J.,Etemad Lida
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference39 articles.
1. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951.
2. WHO Director-General’s opening remarks at the media briefing on COVID19. 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 20 Apr 2020.
3. World Health Organization. Coronavirus disease (COVID-2019) situation reports-90. 2021. https://www.who.int/publications/m/item/weekly-epidemiological-update---2-february-2021. Accessed 05 Feb 2021.
4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
5. Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020;43(7):1399–407.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献